New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 29, 2013
19:17 EDTLIFE, TMOThermo Fisher considering Life Technologies bid, Reuters reports
Thermo Fisher (TMO) has held discussions with Life Technologies (LIFE), which is exploring a potential sale, about a potential deal and Thermo Fisher is considering making an offer for the company, according to a Reuters report that cites three sources familiar with the matter. Reference Link
News For TMO;LIFE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 12, 2015
16:45 EDTTMOThermo Fisher authorizes $1B share repurchase plan
Thermo Fisher Scientific announced its board of directors authorized the repurchase of $1B of shares of its common stock. The repurchase authorization replaces the existing authorization, in which there was approximately $410M remaining. The company intends to resume share repurchases in 2016, said Thermo Fisher.
November 11, 2015
07:33 EDTLIFEaTyr Pharma selects second IND candidate for pulmonary diseases
aTyr Pharma has selected an Investigational New Drug Candidate based on an immuno-modulatory and fibro-modulating Physiocrine domain fused to an Fc region of a human antibody, iMod.Fc. The selected iMod.Fc molecule is intended to address patients with severe pulmonary diseases with an immune and fibrotic component. In preclinical studies in a well-established rodent model of lung inflammation and pulmonary fibrosis, when given in two therapeutic doses, this iMod.Fc molecule was comparable to, or outperformed, approved drugs in reducing lung inflammation and fibrosis in the bleomycin model. The company is initiating GMP process development with a third party manufacturer. The selected iMod.Fc molecule is the company's second physiocrine-based therapeutic development candidate.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use